Q4 2026 Emcure Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good team and welcome to the Q4 FY26 Earnings Conference Call of MQL Pharmaceuticals Limited.
(Operator Instructions).
Please note that this conference is being recorded.
I now hand the conference over to Mr. Saurav Baliwal.
Thank you and over to you, sir.
Thank you. Good afternoon, everyone, and welcome to the Q4F526 Earnings Conference Call for Intel Pharmaceuticals.
Thank you for joining us today. I am Saurav Baliwal, and we'll begin today with brief opening remarks from the management, and then open the line for Q&A after the commentary concludes.
Joining me today on the call are Mr. Satish Mehta, Managing Director and CEO; Mr. Taj Shaikh, Chief Financial Officer; Mr. Samit Mehta, full-time Director Mr. Vikas Thapa, President, Corporate Development and Strategy and Finance.
And Mr. Piyush Nahar, Executive Vice President, Corporate Development and Strategy. We hope you have had an opportunity to review the financial results, the results
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
